These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31685213)

  • 1. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients ≥70 Years of Age.
    Auffret V; Laurin C; Leurent G; Didier R; Filippi E; Hacot JP; Zabalawi A; Rouault G; Saouli D; Druelles P; Coudert I; Boulanger B; Bot E; Treuil J; Bedossa M; Boulmier D; Loirat A; Sharobeem S; Guellec ML; Gilard M; Breton HL
    Am J Cardiol; 2020 Jan; 125(1):1-10. PubMed ID: 31685213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.
    Bainey KR; Armstrong PW; Zheng Y; Brass N; Tyrrell BD; Leung R; Westerhout CM; Welsh RC
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008059. PubMed ID: 31607152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
    Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry.
    Zubaid M; Khraishah H; Alahmad B; Rashed W; Ridha M; Alenezi F; Aljarralah M; Al-Marri K; Almutairi M; Althalji K; Alfaddagh A
    Ann Glob Health; 2020 Feb; 86(1):13. PubMed ID: 32064231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry.
    Pimor A; Auffret V; Didier R; Delaunay R; Filippi E; Hacot JP; Saouli D; Rouault G; Druelles P; Bot E; Coudert I; Boulanger B; Le Guellec M; Boulmier D; Leurent G; Bedossa M; Gilard M; Le Breton H
    Arch Cardiovasc Dis; 2018 Nov; 111(11):656-665. PubMed ID: 29229216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).
    Siontis KC; Barsness GW; Lennon RJ; Holmen JL; Wright RS; Bell MR; Gersh BJ
    Am J Cardiol; 2016 Jun; 117(12):1904-10. PubMed ID: 27131614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Nonagenarians With ST Elevation Myocardial Infarction.
    Cepas-Guillén PL; Borrego-Rodriguez J; Flores-Umanzor E; Echarte-Morales J; Fernandez-Valledor A; Menendez-Suarez P; Vazquez S; Alonso N; Ortiz JT; Regueiro A; Iglesias I; Andrea R; Masotti M; Perez de Prado A; Brugaletta S; Bayón-Fernandez J; Freixa X; Fernandez-Vazquez F; Sabaté M
    Am J Cardiol; 2020 Jan; 125(1):11-18. PubMed ID: 31732135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Reperfusion Strategies in Patients with ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK) Trial.
    Khraishah H; Alahmad B; Secemsky E; Young MN; ElGuindy A; Siedner MJ; Kassab M; Kholte D; Khanbhai K; Janabi M; Kennedy K; Albaghdadi MS
    Glob Heart; 2020 Oct; 15(1):68. PubMed ID: 33150133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention-Capable Hospitals.
    Tran DT; Welsh RC; Ohinmaa A; Thanh NX; Kaul P
    Can J Cardiol; 2017 Apr; 33(4):485-492. PubMed ID: 28256426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study.
    Welsh RC; Goldstein P; Sinnaeve P; Ostojic MC; Zheng Y; Danays T; Westerhout CM; Van de Werf F; Armstrong PW
    Eur Heart J Acute Cardiovasc Care; 2018 Sep; 7(6):504-513. PubMed ID: 28627230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry).
    García-García C; Oliveras T; Rueda F; Pérez-Fernández S; Ferrer M; Serra J; Labata C; Vila J; Carrillo X; Rodríguez-Leor O; Fernández-Nofrerias E; Faixedas MT; Jiménez J; Mauri J; Lupón J; Bayes-Genis A
    Am J Cardiol; 2018 Aug; 122(4):529-536. PubMed ID: 29960663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System.
    Rashid MK; Guron N; Bernick J; Wells GA; Blondeau M; Chong AY; Dick A; Froeschl MPV; Glover CA; Hibbert B; Labinaz M; Marquis JF; Osborne C; So DY; Le May MR
    JACC Cardiovasc Interv; 2016 Oct; 9(19):2014-2020. PubMed ID: 27712737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Comparing Primary Percutaneous Coronary Intervention Versus Pharmacoinvasive Therapy in Transfer Patients with ST-Elevation Myocardial Infarction.
    Siddiqi TJ; Usman MS; Khan MS; Sreenivasan J; Kassas I; Riaz H; Raza S; Deo SV; Sharif H; Kalra A; Yadav N
    Am J Cardiol; 2018 Aug; 122(4):542-547. PubMed ID: 30205885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry.
    Puymirat E; Caudron J; Steg PG; Lemesle G; Cottin Y; Coste P; Schiele F; de Labriolle A; Bataille V; Ferrières J; Simon T; Danchin N;
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):26-33. PubMed ID: 26450784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico City.
    Arias-Mendoza A; Gopar-Nieto R; Juarez-Tolen J; Ordóñez-Olvera JC; Gonzalez-Pacheco H; Briseño-De la Cruz JL; Sierra-Lara Martinez D; Mendoza-García S; Altamirano-Castillo A; Montañez-Orozco A; Arzate-Ramirez A; Baeza-Herrera LA; Ortega-Hernandez JA; Miranda-Cerda G; Cruz-Martinez JE; Baranda-Tovar FM; Zabal-Cerdeira C; Araiza-Garaygordobil D
    Am J Cardiol; 2024 May; 218():7-15. PubMed ID: 38402926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
    Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
    Cornara S; Somaschini A; De Servi S; Crimi G; Ferlini M; Baldo A; Camporotondo R; Gnecchi M; Ferrario Ormezzano M; Oltrona Visconti L; De Ferrari GM
    Am J Cardiol; 2017 Nov; 120(10):1734-1741. PubMed ID: 28865893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.